Inflammaging as a prodrome to Alzheimer's disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic hypotheses and preclinical animal data without primary human trial data
PubMed 19014446 · doi:10.1186/1742-2094-5-51
What was done
This narrative review synthesizes evidence surrounding "inflammaging"—characterized by elevated innate immune activity and declining adaptive immunity—and evaluates its potential role as a prodromal driver of Alzheimer's disease (AD). The authors also examine preclinical findings in mouse models for three therapeutic approaches aimed at mitigating inflammaging and AD-like pathology: human umbilical cord blood cells (HUCBC), flavonoids, and amyloid-beta (Abeta) vaccination.
What was found
The abstract reports no primary quantitative data or statistical comparisons. It outlines mechanistic evidence showing that pro-inflammatory cytokines, including IFN-gamma, influence the processing and production of Abeta. It proposes that individuals with heightened inflammatory genotypes transition from subclinical inflammaging to AD pathology, whereas successful agers engage counter-regulatory anti-inflammatory mechanisms. Preclinical mouse data are described as showing reduction of inflammaging features and AD-like pathology following treatment with HUCBC, flavonoids, or Abeta vaccination.
Why it matters
The paper highlights chronic, low-grade systemic and innate inflammation as an upstream contributor to Alzheimer's pathology rather than a passive byproduct. This conceptual model supports exploring anti-inflammatory and immune-rebalancing interventions prior to extensive neurodegeneration.
Limits
The review relies on conceptual frameworks and preclinical animal models without presenting primary clinical trial data or quantitative effect sizes in humans. It does not follow a systematic review methodology, leaving it subject to narrative selection bias.
Cited by
- supports As the immune system ages, it shifts from specific responses toward non-specific inflammatory responses.